Cambridge Investment Research Advisors Inc. Sells 3,946 Shares of Livent Co. (NYSE:LTHM)

Cambridge Investment Research Advisors Inc. reduced its stake in shares of Livent Co. (NYSE:LTHM – Get Rating) by 8.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 42,180 shares of the company’s stock after selling 3,946 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Livent were worth $838,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of the stock. BlackRock Inc. boosted its position in Livent by 8.3% during the 3rd quarter. BlackRock Inc. now owns 28,159,121 shares of the company’s stock valued at $863,078,000 after buying an additional 2,156,474 shares during the period. Vanguard Group Inc. grew its stake in shares of Livent by 10.2% in the third quarter. Vanguard Group Inc. now owns 19,659,039 shares of the company’s stock worth $602,549,000 after purchasing an additional 1,812,971 shares during the last quarter. First Republic Investment Management Inc. increased its holdings in Livent by 5,080.3% during the 2nd quarter. First Republic Investment Management Inc. now owns 660,384 shares of the company’s stock valued at $14,984,000 after purchasing an additional 647,636 shares during the period. Leeward Investments LLC MA raised its position in Livent by 41.9% during the 4th quarter. Leeward Investments LLC MA now owns 1,603,713 shares of the company’s stock valued at $31,866,000 after purchasing an additional 473,476 shares during the last quarter. Finally, Renaissance Technologies LLC lifted its holdings in Livent by 156.7% in the 3rd quarter. Renaissance Technologies LLC now owns 759,200 shares of the company’s stock worth $23,269,000 after buying an additional 463,500 shares during the period. Hedge funds and other institutional investors own 90.62% of the company’s stock.

Livent Trading Down 1.9 %

NYSE:LTHM opened at $24.89 on Monday. The firm has a market capitalization of $4.47 billion, a P/E ratio of 15.36, a PEG ratio of 0.42 and a beta of 1.81. The company has a debt-to-equity ratio of 0.16, a current ratio of 4.23 and a quick ratio of 2.83. Livent Co. has a one year low of $18.26 and a one year high of $36.38. The company’s 50-day simple moving average is $22.01 and its 200 day simple moving average is $23.82.

Livent (NYSE:LTHM – Get Rating) last issued its quarterly earnings results on Tuesday, May 2nd. The company reported $0.60 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.21. Livent had a return on equity of 26.15% and a net margin of 36.30%. The firm had revenue of $235.50 million for the quarter, compared to analysts’ expectations of $229.94 million. During the same period in the previous year, the firm posted $0.21 EPS. The business’s revenue for the quarter was up 64.1% compared to the same quarter last year. As a group, analysts forecast that Livent Co. will post 2.01 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have recently issued reports on LTHM. Bank of America raised Livent from a “neutral” rating to a “buy” rating and reduced their target price for the company from $29.00 to $27.00 in a research note on Wednesday, April 5th. Mizuho reduced their price objective on shares of Livent from $30.00 to $29.00 in a research report on Thursday, May 4th. CICC Research raised shares of Livent from a “market perform” rating to an “outperform” rating in a research report on Thursday, May 4th. B. Riley upgraded shares of Livent from a “neutral” rating to a “buy” rating and set a $32.00 price target on the stock in a research report on Thursday, May 11th. Finally, Raymond James lowered their price objective on shares of Livent from $35.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, April 5th. Five equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $29.43.

Livent Profile

(Get Rating)

Livent Corp. engages in the production of performance lithium compounds. Its products include battery-grade lithium hydroxide, butyllithium, and purity lithium metal which are used in various performance applications. It operates through the following geographical segments: North America, Europe, Middle East, and Africa, Latin America, and Asia Pacific.